The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
about
The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the ratIs peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospectsIcosapent ethyl for the treatment of severe hypertriglyceridemia.A heterodimer of the Zn2Cys6 transcription factors Pip2p and Oaf1p controls induction of genes encoding peroxisomal proteins in Saccharomyces cerevisiae.Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting proteinSuppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4Mammalian hibernation: cellular and molecular responses to depressed metabolism and low temperatureClofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodentsThe organization, promoter analysis, and expression of the human PPARgamma genep300 functions as a coactivator for the peroxisome proliferator-activated receptor alphaNovel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effectsExpression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidneyTroglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker ratsHypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and deltaAutophagy in the liver: cell's cannibalism and beyondInvolvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast DifferentiationActivation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liverA PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesisComparative proteome analysis of TGF-beta1-induced fibrosis processes in normal rat kidney interstitial fibroblast cells in response to ascofuranoneCyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdeltaLipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN studyClustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapyMitochondrial Trifunctional Protein Defects: Clinical Implications and Therapeutic ApproachesDescribing the Diapause-Preparatory Proteome of the Beetle Colaphellus bowringi and Identifying Candidates Affecting Lipid Accumulation Using Isobaric Tags for Mass Spectrometry-Based Proteome Quantification (iTRAQ).Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells.Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathwayEffect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese micePeroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effectConcurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retentionA mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha.Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes
P2860
Q24530668-60B111F9-7441-4FB6-8DBD-67E860C37305Q24799696-E68FBA26-CF02-45DA-A478-C8B4FA1DE026Q24812167-2B6A163E-DA43-4BF8-8FD1-579DC7D74912Q26829098-DC28C051-2AD7-40B1-B848-70116D25E2FDQ27686834-7D25893F-05CA-4639-9EAD-39218D07C553Q27934013-E943BF02-577C-4156-B6B6-F010209C0960Q28115776-8DE64A2D-E384-4E64-96EA-9D5D054C1C5AQ28144400-98404D13-294E-4A10-930B-4E672823846FQ28202578-7CE73E94-5C48-49BB-AC31-F399E05217B8Q28204734-ACFE5D8E-0D26-49F1-A002-55C32859E9E7Q28222350-5695E148-62FA-4545-BD32-800F98733E2AQ28244071-9EE4CE44-C4B6-4119-867D-1D6CD75CB944Q28257373-BB7A8DDD-644A-4609-B736-0F6E38DB6B11Q28370354-D1C7C9CD-7DC6-4EF1-BD73-3E39840671CCQ28377689-07AC41CB-4E3A-4CFA-ABDB-482A062E9B90Q28379378-37C637E4-B718-4A44-93BD-D2341D099851Q28379553-9C88D57E-F355-43B6-A5BA-EAD94FFBD91FQ28388115-9DEA4D9F-2A7B-401B-8C3B-07C993B9A89FQ28548626-2DC99ACE-D1A0-4E49-8904-A0D86C36A439Q28570588-B713BE26-5C59-4CA1-9F44-28C9834FE666Q28571692-0372ECCA-AFC5-4EB9-B713-A52D104DE86AQ28574899-B648B2E3-207A-4BE2-9BE4-B0ACFF03ED01Q28587698-11FF2AF7-7CD6-4ABB-A93D-E7A3741A02EEQ28607159-1992EFCC-9A6A-4407-B119-6942E2E95BF6Q28728567-8C856475-7062-42D4-B2F3-DDFD276B1FDEQ28972544-A12C51DF-E1C7-42BD-A339-63A740FE31C1Q30846986-D83D7CFD-5FE0-4FAF-9B14-C295F8EEA402Q33264199-A462CC2D-D417-4DDA-8852-C7336FDECB28Q33380951-FB144FAF-4210-4438-9AFA-73AD2D76DEDCQ33384638-E24577A1-B552-47FA-A17D-3E60EF2AF5FEQ33589182-E2D0548D-894B-4945-B8BD-612E7FBFC6C4Q33593476-77D326B6-254A-4E28-BED0-475DD35F4122Q33750744-75947B15-21FA-4E47-A6EC-24CFA5F1ECFBQ33753420-FCF4B6BF-19BA-4236-9475-0815E2D0EEB2Q33864191-DFAE3FF5-3422-4C19-B065-804DB09A33C0Q33876924-A6644DA2-5E9E-4F0E-B40C-03DA01325139Q33878917-77598480-717B-4CDE-BE5D-3162B4D9ADBBQ33890145-428F1754-1E94-4250-BA65-45262D30F2F6Q33933474-08C01227-6BFF-4601-AF3F-EEDB43E8EE8AQ33955477-0A0E24F9-A7E5-459D-A695-4DFBB0CE03B7
P2860
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The peroxisome proliferator ac ...... and adipocyte differentiation.
@en
type
label
The peroxisome proliferator ac ...... and adipocyte differentiation.
@en
prefLabel
The peroxisome proliferator ac ...... and adipocyte differentiation.
@en
P1476
The peroxisome proliferator ac ...... and adipocyte differentiation.
@en
P2093
K Schoonjans
P304
P356
10.1016/0005-2760(96)00066-5
P577
1996-07-01T00:00:00Z